565 related articles for article (PubMed ID: 16469851)
1. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
[TBL] [Abstract][Full Text] [Related]
2. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
3. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
[TBL] [Abstract][Full Text] [Related]
4. Macrolide-resistant Staphylococcus aureus colonization in cystic fibrosis patients: is there transmission to household contacts?
Tramper-Stranders GA; van der Ent CK; Gerritsen SA; Fleer A; Kimpen JL; Wolfs TF
J Antimicrob Chemother; 2007 Sep; 60(3):665-8. PubMed ID: 17604321
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
[TBL] [Abstract][Full Text] [Related]
6. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
[TBL] [Abstract][Full Text] [Related]
7. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis.
Roberts MC; Soge OO; No DB
J Antimicrob Chemother; 2011 Jan; 66(1):100-4. PubMed ID: 21081549
[TBL] [Abstract][Full Text] [Related]
8. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
Pirzada OM; McGaw J; Taylor CJ; Everard ML
J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
[TBL] [Abstract][Full Text] [Related]
9. [Drug susceptibility of Haemophilus sp. and Staphylococcus aureus strains colonizing respiratory tract in children with mucoviscidosis].
Kosikowska U; Juda M; Malm A; Jóźwiakowska M; Tuszkiewicz-Misztal E
Przegl Epidemiol; 2007; 61(2):377-84. PubMed ID: 17956057
[TBL] [Abstract][Full Text] [Related]
10. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains.
Prunier AL; Malbruny B; Laurans M; Brouard J; Duhamel JF; Leclercq R
J Infect Dis; 2003 Jun; 187(11):1709-16. PubMed ID: 12751028
[TBL] [Abstract][Full Text] [Related]
11. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
Kabra SK; Pawaiya R; Lodha R; Kapil A; Kabra M; Vani AS; Agarwal G; Shastri SS
J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
[TBL] [Abstract][Full Text] [Related]
12. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation.
Molina A; Del Campo R; Máiz L; Morosini MI; Lamas A; Baquero F; Cantón R
J Antimicrob Chemother; 2008 Nov; 62(5):961-7. PubMed ID: 18647744
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of azithromycin in patients with cystic fibrosis.
Samson C; Tamalet A; Thien HV; Taytard J; Perisson C; Nathan N; Clement A; Boelle PY; Corvol H
Respir Med; 2016 Aug; 117():1-6. PubMed ID: 27492507
[TBL] [Abstract][Full Text] [Related]
14. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
Karlowsky JA; Lagacé-Wiens PR; Low DE; Zhanel GG
Int J Antimicrob Agents; 2009 Oct; 34(4):375-9. PubMed ID: 19560902
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Staphylococcus aureus Strains Isolated from Czech Cystic Fibrosis Patients: High Rate of Ribosomal Mutation Conferring Resistance to MLS(B) Antibiotics as a Result of Long-Term and Low-Dose Azithromycin Treatment.
Tkadlec J; Vařeková E; Pantůček R; Doškař J; Růžičková V; Botka T; Fila L; Melter O
Microb Drug Resist; 2015 Aug; 21(4):416-23. PubMed ID: 25826283
[TBL] [Abstract][Full Text] [Related]
17. High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations.
Goerke C; Gressinger M; Endler K; Breitkopf C; Wardecki K; Stern M; Wolz C; Kahl BC
Environ Microbiol; 2007 Dec; 9(12):3134-42. PubMed ID: 17991040
[TBL] [Abstract][Full Text] [Related]
18. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
19. [Isolated pathogen microorganisms in respiratory samples from children with cystic fibrosis].
Anzaudo MM; Busquets NP; Ronchi S; Mayoral C
Rev Argent Microbiol; 2005; 37(3):129-34. PubMed ID: 16323660
[TBL] [Abstract][Full Text] [Related]
20. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
